Medical Supplies for Pandemics Act of 2021
- Last Action
- 5/19/2021
Actions
- 2021-05-19Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2021-05-19Introduced in Senate
CRS Summary
As of 2021-05-19 (00)
Medical Supplies for Pandemics Act of 2021
This bill requires the Department of Health and Human Services (HHS) to take specified actions, as part of its management of the Strategic National Stockpile, to establish and maintain domestic reserves of critical medical supplies.
Specifically, HHS must (1) create incentives for domestic manufacturers of medical supplies to increase emergency stocks and diversify geographic production; (2) purchase, lease, or enter into joint ventures with respect to facilities and equipment to produce medical supplies; and (3) work with distributors to refresh and replenish medical supplies. HHS must also submit a report to Congress concerning the details of any purchase, lease, or joint venture.
The department's authority under the bill to make purchases, leases, or joint ventures for medical supplies terminates on September 30, 2024.
Cosponsors (1)
- Thomas Tillis (R-NC)
Subjects
- Congressional oversight
- Emergency medical services and trauma care
- Health programs administration and funding
- Health technology, devices, supplies
- Immunology and vaccination
- Manufacturing
- Medical tests and diagnostic methods
- Prescription drugs
- Public contracts and procurement
- Strategic materials and reserves
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.